GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.710
-0.040 (-1.45%)
At close: Dec 5, 2025, 4:00 PM EST
2.711
+0.001 (0.04%)
After-hours: Dec 5, 2025, 7:34 PM EST
GoodRx Holdings Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for GoodRx Holdings stock ranges from a low of $4.00 to a high of $7.00. The average analyst price target of $5.48 forecasts a 102.21% increase in the stock price over the next year.
Price Target: $5.48 (+102.21%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Buy | 6 | 4 | 4 | 4 | 4 | 3 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 9 | 9 | 9 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +84.50% | Nov 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +121.40% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $4.25 → $4 | Hold | Maintains | $4.25 → $4 | +47.60% | Nov 6, 2025 |
| Mizuho | Mizuho | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +47.60% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $5.25 → $4.25 | Hold | Maintains | $5.25 → $4.25 | +56.83% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
810.57M
from 792.32M
Increased by 2.30%
Revenue Next Year
834.13M
from 810.57M
Increased by 2.91%
EPS This Year
0.37
from 0.04
Increased by 817.77%
EPS Next Year
0.45
from 0.37
Increased by 22.20%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 836.5M | 892.3M | ||||
| Avg | 810.6M | 834.1M | ||||
| Low | 777.1M | 773.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.6% | 10.1% | ||||
| Avg | 2.3% | 2.9% | ||||
| Low | -1.9% | -4.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.40 | 0.53 | |||
| Avg | 0.37 | 0.45 | |||
| Low | 0.33 | 0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 897.5% | 43.0% | |||
| Avg | 817.8% | 22.2% | |||
| Low | 733.0% | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.